Imagin Medical Inc.
IMEXF · OTC
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.00 | -0.45 | 0.00 |
| FCF Yield | 1.64% | -23.14% | -8.06% | -36.10% |
| EV / EBITDA | -41.07 | -18.96 | 243.75 | -3.54 |
| Quality | ||||
| ROIC | 29.78% | 49.01% | 165.22% | -912.09% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.01 | 0.55 | -14.49 | 0.07 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | 103.63% | -109.04% | 78.57% | -58.70% |
| Safety | ||||
| Net Debt / EBITDA | -37.40 | -16.42 | 199.25 | -2.89 |
| Interest Coverage | -252.59 | -212.35 | -293.13 | -502.29 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -2,023.93 | -1,970.26 | -1,955.69 | -2,700.46 |